Connect Biopharma Holdings Ltd - 10-Q Filing
Connect Biopharma Holdings Ltd filed its Q1 2026 Form 10-Q on April 30, 2026, reporting unaudited financial results for the three months ended March 31, 2026. The filing includes condensed consolidated balance sheets showing $458 million in cash and cash equivalents as of March 31, 2026, compared to $479 million at December 31, 2025.
Tickers: $CNTB